PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Oct-2024 New Sales Contract with a Healthcare Company Celadon Pharmaceuticals Plc
03-Oct-2024 Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient Heidelberg Pharma
03-Oct-2024 Pentixapharm Holding AG Completes IPO in the Prime Standard of the Frankfurt Stock Exchange Pentixapharm Holding AG
03-Oct-2024 Lonza Nominates David Meline as Independent Board Member Lonza Group AG
03-Oct-2024 Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance ABIVAX
02-Oct-2024 Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in July Biotest AG
02-Oct-2024 Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register Eckert & Ziegler SE
01-Oct-2024 Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed Pentixapharm Holding AG
01-Oct-2024 Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient Heidelberg Pharma AG
01-Oct-2024 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
01-Oct-2024 Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche Lonza Group AG
01-Oct-2024 Heidelberg Pharma AG Announces Updated Guidance Heidelberg Pharma AG
01-Oct-2024 Kyowa Kirin Presents Real-World Evidence Demonstrating Clinically Meaningful Impact of Burosumab Treatment in Adults with X-linked Hypophosphatemia Kyowa Kirin
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE® (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals
01-Oct-2024 Nxera Pharma Appoints Experienced Commercial R&D Executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan Nxera Pharma
01-Oct-2024 Celadon Pharmaceuticals Plc Departure of Chief Financial Officer
01-Oct-2024 Cherwell’s new Microbiology Product Specialist to share insights on EM for pharmaceutical quality assurance at QATS Symposium CHERWELL LABORATORIES
01-Oct-2024 Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 Mainz BioMed N.V.
01-Oct-2024 Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission Drägerwerk AG & Co. KGaA